Contact Information

Oak Avenue, Manhattan Beach, California 90266

Contact Us

GlycoMimetics Inc. (GLYC) posted a $15.6 million loss in the fourth quarter on Tuesday.

The company, based in Rockville, Maryland, posted a loss of 32 cents per share.

The findings were as predicted by Wall Street. A loss of 32 cents per share was also expected by five analysts polled by Zacks Investment Research.

During that time, the biotechnology business gained $163,000 in sales.

The company’s loss for the year was estimated to be $51 million, or $1.12 per share. $10.2 million in revenue was registered.

The company’s stock finished the day at $3.59. They were trading at $3.49 a year ago.


READ:  Biden's $1.9 Trillion Bailout has Been Signed, but the Agenda in Congress is Now a Slog.
Notify of
Inline Feedbacks
View all comments